Skip to main content
BLSM
NASDAQ Life Sciences

BlossomHill Posts $8.75 Q2 Loss Per Share in First Report Since IPO

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Healthcare
Sentiment info
Neutral
Importance info
7
Price
$26.51
Mkt Cap
$821.863M
52W Low
$15.6
52W High
$27.8
52W Position info
70% above low
Off High info
4.6% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

BLSM sits 70% above its 52-week low of $15.6.

Summary

BlossomHill reported a Q2 loss of $8.75 per share, its first quarterly result since the August IPO. The company's Q2 net loss was $23.8 million, reflecting heavy R&D spending on BH-30643, which recently showed a 45% objective response rate in Phase 1/2 SOLARA data. BlossomHill raised $150 million at $16.00 per share in its IPO, and the stock now trades near its 52-week high of $27.80, suggesting investors are focused on clinical progress rather than near-term profitability. The company has raised $168.3 million in total from the IPO, and its cash runway is expected to fund operations into 2Q 2028. The loss is in line with expectations for a clinical-stage biotech, but the magnitude underscores the cash burn rate.

At the time of this announcement, BLSM was trading at $26.51 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $821.9M. The 52-week trading range was $15.60 to $27.80. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

BLSM - Latest Insights

BLSM
Nov 12, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $14.84
Real-time Price: $14.02 info
Change: -$0.820 (-6%) info
Market Cap: $445.624M info
BLSM
Nov 12, 2026, 4:01 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $14.84
Real-time Price: $14.02 info
Change: -$0.820 (-6%) info
Market Cap: $445.624M info
BLSM
Sep 15, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $23.19
Real-time Price: $14.02 info
Change: -$9.17 (-40%) info
Market Cap: $445.624M info
BLSM
Aug 18, 2026, 4:53 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $16.10
Real-time Price: $14.02 info
Change: -$2.08 (-13%) info
Market Cap: $445.624M info
BLSM
Aug 18, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $17.14
Real-time Price: $14.02 info
Change: -$3.12 (-18%) info
Market Cap: $445.624M info